Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWAP-5: Switching Between Cangrelor and Ticagrelor
NCT04634162Phase 4Completed
- Sponsor
- University of Florida
- Start
- Feb 2021
- Primary completion
- Aug 2021
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of cangrelor in coronary artery disease (CAD), sponsored by University of Florida. Started Feb 2021; status: completed.
02
Drugs
cangrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04634162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04634162.